Pathological features of prostate cancer in men treated with robot-assisted radical prostatectomy in the Middle East.
Adenocarcinoma
/ epidemiology
Aged
Humans
Incidence
Kuwait
/ epidemiology
Length of Stay
/ statistics & numerical data
Male
Margins of Excision
Middle Aged
Neoplasm Recurrence, Local
/ epidemiology
Neoplasm Staging
Prostatectomy
/ methods
Prostatic Neoplasms
/ epidemiology
Retrospective Studies
Robotic Surgical Procedures
/ methods
Treatment Outcome
Middle East
Pathological outcomes
Prostatectomy
Robotics
Journal
Journal of robotic surgery
ISSN: 1863-2491
Titre abrégé: J Robot Surg
Pays: England
ID NLM: 101300401
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
18
04
2020
accepted:
29
04
2020
pubmed:
8
5
2020
medline:
27
7
2021
entrez:
8
5
2020
Statut:
ppublish
Résumé
Little is known about the pathological features of radical prostatectomy among men living in the Middle East. Although prostate cancer became the most common malignancy among males in some countries in the Middle East, the incidence is much lower compared to western populations. The aim of this study is to analyze pathological features and biochemical recurrence in men who underwent robotic-assisted radical prostatectomy (RARP) in Kuwait. The data on all RARP cases performed by a uro-oncologist (SA) were recorded. A comprehensive database was collected, including demographic, clinical, and pathological data. Between February 2014 and November 2019, 65 RARP cases were performed out of a total of 200 robotic urological procedures. The median follow-up was 41.5 months [inter quartile range (IQR) 27.6-52.7]. Eleven (17%) complications occurred in 7 patients, 64% were early (< 30 days post-operatively) and minor (Clavien I-II). Thirty-five (54%) patients had ≥ pT3 disease. Overall, 12 (18%) patients had a positive surgical margin (PSM), and all had ≥ pT3 disease. Potency and continence rates at 12 months were 82% and 97%, respectively. The mean and SD of the hospital stay were 2.7 ± 1.1 days. Biochemical recurrence (BCR) rate was 10%. Men with prostatic adenocarcinoma treated with RARP in Kuwait show a high incidence of pT3 disease. PSM and BCR rates were similar to multiple reports in the literature. To our knowledge, this is the first report of RARP pathological outcomes in the gulf cooperation council (GCC) region of the Middle East.
Identifiants
pubmed: 32378083
doi: 10.1007/s11701-020-01089-0
pii: 10.1007/s11701-020-01089-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
125-133Références
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30. https://doi.org/10.3322/caac.21442
doi: 10.3322/caac.21442
pubmed: 29313949
Al-Othman S, Haoudi A, Alhomoud S, Alkhenizan A, Khoja T, Al-Zahrani A (2015) Tackling cancer control in the Gulf cooperation council countries. Lancet Oncol 16(5):e246–e257. https://doi.org/10.1016/S1470-2045(15)70034-3
doi: 10.1016/S1470-2045(15)70034-3
pubmed: 25943069
Kulhanova I, Bray F, Fadhil I, Al-Zahrani AS, El-Basmy A, Anwar WA, Al-Omari A, Shamseddine A, Znaor A, Soerjomataram I (2017) Profile of cancer in the Eastern Mediterranean region: the need for action. Cancer Epidemiol 47:125–132. https://doi.org/10.1016/j.canep.2017.01.009
doi: 10.1016/j.canep.2017.01.009
pubmed: 28268206
Mukherji D, Youssef B, Dagher C, El-Hajj A, Nasr R, Geara F, Rabah D, Al Dousari S, Said R, Ashou R, Wazzan W, Jabbour M, Farha G, Al Hamdani N, Al Hallaq Y, Ghazal H, Dbouk H, Bachir B, El Khoury C, Sakr G, Hussain HK, Sayyid K, Ibrahim K, Haidar M, Zouain N, Bitar N, Alameh W, Abbas F, Faddoul S, Nemer E, Assaf G, Farhat F, Bulbul M, Temraz S, Shamseddine A, Gillessen S, Omlin A, Khauli R (2020) Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations. World J Urol 38(3):681–693. https://doi.org/10.1007/s00345-019-02872-x
doi: 10.1007/s00345-019-02872-x
pubmed: 31297628
Rabah DM, Al-Abdin OZ (2012) The development of robotic surgery in the Middle East. Arab J Urol 10(1):10–16. https://doi.org/10.1016/j.aju.2011.12.001
doi: 10.1016/j.aju.2011.12.001
pubmed: 26557999
pmcid: 4442898
Al-Othman KE, Al-Hellow HA, Al-Zahrani HM, Seyam RM (2008) Robotic augmentation enterocystoplasty. J Endourol 22(4):597–600. https://doi.org/10.1089/end.2007.9835 (discussion 600)
doi: 10.1089/end.2007.9835
pubmed: 18324897
Rabah DM, Alyami FA (2008) Robotic-assisted transperitoneal radical prostatectomy in a patient with pelvic kidney. Saudi Med J 29(2):288–290
pubmed: 18246243
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196. https://doi.org/10.1097/SLA.0b013e3181b13ca2
doi: 10.1097/SLA.0b013e3181b13ca2
pubmed: 19638912
Matsuda Y, Hisasue S, Kumamoto Y, Kobayashi K, Hashimoto K, Sato Y, Masumori N (2014) Correlation between erection hardness score and nocturnal penile tumescence measurement. J Sex Med 11(9):2272–2276. https://doi.org/10.1111/jsm.12617
doi: 10.1111/jsm.12617
pubmed: 24919744
Azhar RA, Bochner B, Catto J, Goh AC, Kelly J, Patel HD et al (2016) Enhanced recovery after urological surgery: a contemporary systematic review of outcomes, key elements, and research needs. Eur Urol 70(1):176–187. https://doi.org/10.1016/j.eururo.2016.02.051
doi: 10.1016/j.eururo.2016.02.051
pubmed: 26970912
pmcid: 5514421
Montironi R, Cheng L, Scarpelli M, Lopez-Beltran A (2018) From Gleason grading system and high-grade tertiary patterns to grade groups and integrated quantitative Gleason score. Eur Urol 73(5):684–686. https://doi.org/10.1016/j.eururo.2017.01.038
doi: 10.1016/j.eururo.2017.01.038
pubmed: 28169016
Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB (2018) Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol 73(4):560–569. https://doi.org/10.1016/j.eururo.2017.12.018
doi: 10.1016/j.eururo.2017.12.018
pubmed: 29325693
D'Amico AV, Moul JW, Carroll PR, Sun L, Lubeck D, Chen MH (2003) Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst 95(18):1376–1383. https://doi.org/10.1093/jnci/djg043
doi: 10.1093/jnci/djg043
pubmed: 13130113
Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, Bianchi M, Sun M, Freschi M, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F (2012) Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol 61(3):480–487. https://doi.org/10.1016/j.eururo.2011.10.044
doi: 10.1016/j.eururo.2011.10.044
pubmed: 22078338
Mir MC, Zargar H, Bolton DM, Murphy DG, Lawrentschuk N (2015) Enhanced recovery after surgery protocols for radical cystectomy surgery: review of current evidence and local protocols. ANZ J Surg 85(7–8):514–520. https://doi.org/10.1111/ans.13043
doi: 10.1111/ans.13043
pubmed: 25781409
Fuller A, Pautler SE (2013) Complications following robot-assisted radical prostatectomy in a prospective Canadian cohort of 305 consecutive cases. Can Urol Assoc J 7(3–4):116–121. https://doi.org/10.5489/cuaj.11116
doi: 10.5489/cuaj.11116
pubmed: 22398201
Ficarra V, Novara G, Fracalanza S, D'Elia C, Secco S, Iafrate M, Cavalleri S, Artibani W (2009) A prospective, non-randomized trial comparing robot-assisted laparoscopic and retropubic radical prostatectomy in one European institution. BJU Int 104(4):534–539. https://doi.org/10.1111/j.1464-410X.2009.08419.x
doi: 10.1111/j.1464-410X.2009.08419.x
pubmed: 19281468
Chen H, Lian B, Dong Z, Wang Y, Qu M, Zhu F, Sun Y, Gao X (2020) Experience of one single surgeon with the first 500 robot-assisted laparoscopic prostatectomy cases in mainland China. Asian J Urol 7(2):170–176. https://doi.org/10.1016/j.ajur.2019.12.004
doi: 10.1016/j.ajur.2019.12.004
pubmed: 32257810
Ou YC, Yang CR, Wang J, Cheng CL, Patel VR (2010) Robotic-assisted laparoscopic radical prostatectomy: learning curve of first 100 cases. Int J Urol 17(7):635–640. https://doi.org/10.1111/j.1442-2042.2010.02546.x
doi: 10.1111/j.1442-2042.2010.02546.x
pubmed: 20438586
Patel VR, Coelho RF, Rocco B, Orvieto M, Sivaraman A, Palmer KJ, Kameh D, Santoro L, Coughlin GD, Liss M, Jeong W, Malcolm J, Stern JM, Sharma S, Zorn KC, Shikanov S, Shalhav AL, Zagaja GP, Ahlering TE, Rha KH, Albala DM, Fabrizio MD, Lee DI, Chauhan S (2011) Positive surgical margins after robotic assisted radical prostatectomy: a multi-institutional study. J Urol 186(2):511–516. https://doi.org/10.1016/j.juro.2011.03.112
doi: 10.1016/j.juro.2011.03.112
pubmed: 21680001
Ahlering TE, Woo D, Eichel L, Lee DI, Edwards R, Skarecky DW (2004) Robot-assisted versus open radical prostatectomy: a comparison of one surgeon's outcomes. Urology 63:819–822. https://doi.org/10.1016/j.urology.2004.01.038
doi: 10.1016/j.urology.2004.01.038
pubmed: 15134953
Al-Hathal N, El-Hakim A (2013) Perioperative, oncological and functional outcomes of the first robotic prostatectomy program in Quebec: single fellowship-trained surgeon's experience of 250 cases. Can Urol Assoc J 7:326–332. https://doi.org/10.5489/cuaj.319
doi: 10.5489/cuaj.319
pubmed: 24319511
pmcid: 3854470
Ficarra V, Cavalleri S, Novara G, Aragona M, Artibani W (2007) Evidence from robot-assisted laparoscopic radical prostatectomy: a systematic review. Eur Urol 51(1):45–55. https://doi.org/10.1016/j.eururo.2006.06.017 (discussion 56)
doi: 10.1016/j.eururo.2006.06.017
pubmed: 16854519
Liss M, Osann K, Ornstein D (2008) Positive surgical margins during robotic radical prostatectomy: a contemporary analysis of risk factors. BJU Int 102(5):603–608. https://doi.org/10.1111/j.1464-410X.2008.07672.x
doi: 10.1111/j.1464-410X.2008.07672.x
pubmed: 18435807
pmcid: 4041686
Lawrentschuk N, Evans A, Srigley J, Chin JL, Bora B, Hunter A, McLoed R, Fleshner NE (2011) Surgical margin status among men with organ-confined (pT2) prostate cancer: a population-based study. Can Urol Assoc J 5(3):161–166. https://doi.org/10.5489/cuaj.10085
doi: 10.5489/cuaj.10085
pubmed: 21672475
pmcid: 3114023
Coelho RF, Chauhan S, Palmer KJ, Rocco B, Patel MB, Patel VR (2009) Robotic-assisted radical prostatectomy: a review of current outcomes. BJU Int 104(10):1428–1435. https://doi.org/10.1111/j.1464-410X.2009.08895.x
doi: 10.1111/j.1464-410X.2009.08895.x
pubmed: 19804427
Menon M, Dalela D, Jamil M, Diaz M, Tallman C, Abdollah F, Sood A, Lehtola L, Miller D, Jeong W (2018) Functional recovery, oncologic outcomes and postoperative complications after robot-assisted radical prostatectomy: an evidence-based analysis comparing the retzius sparing and standard approaches. J Urol 199(5):1210–1217. https://doi.org/10.1016/j.juro.2017.11.115
doi: 10.1016/j.juro.2017.11.115
pubmed: 29225060
Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, Menon M, Montorsi F, Patel VR, Stolzenburg JU, van der Poel H, Wilson TG, Zattoni F, Mottrie A (2012) Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 62(3):405–417. https://doi.org/10.1016/j.eururo.2012.05.045
doi: 10.1016/j.eururo.2012.05.045
pubmed: 22749852
Tienforti D, Sacco E, Marangi F, D'Addessi A, Racioppi M, Gulino G, Pinto F, Totaro A, D'Agostino D, Bassi P (2012) Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial. BJU Int 110(7):1004–1010. https://doi.org/10.1111/j.1464-410X.2012.10948.x
doi: 10.1111/j.1464-410X.2012.10948.x
pubmed: 22332815